ReviewAdvances in neurobiology2024
Magnetoencephalography in Psychiatry: A Perspective on Translational Research and Applications.
Review in Advances in neurobiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Magnetoencephalography (MEG) is a neuroimaging technique that has excellent temporal as well as good spatial resolution for measuring neural activity and has been extensively employed in cognitive neuroscience. However, MEG has only been more recently applied to investigations of brain networks and biomarkers in psychiatry. Besides providing new insights into the pathophysiology of major psychiatry syndromes, especially in schizophrenia, a major objective of current research is the identification of biomarkers that could inform early intervention and novel treatments. This chapter will provide a state-of-the-art overview of MEG as applied to schizophrenia, autism spectrum disorders, and Alzheimer's disease, summarizing methodological approaches and studies investigating alterations during resting-state and task-related paradigms. In addition, we will highlight future methodological developments and their potential for applications of MEG in psychiatry.
Indexed as
Identifiers
39562444What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.